Global Neonatal Respiratory Distress Syndrome Treatment Market Overview: Trends Shaping Growth to 2029
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Market Value Is The Neonatal Respiratory Distress Syndrome Treatment Industry Expected To Reach By 2029, Starting From 2025 Levels?
The market for neonatal respiratory distress syndrome treatments has experienced significant expansion in recent years. Its size is projected to expand from $0.96 billion in 2024 to $1.03 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.0%. This historical growth can be linked to several factors, including heightened permeability and fluid build-up within the alveoli, increased alveolar-capillary permeability, a rise in the deployment of mechanical ventilation, a greater understanding among healthcare professionals and parents regarding the significance of neonatal care, and increased financial commitments in healthcare.
The neonatal respiratory distress syndrome treatment market size is projected to experience robust expansion in the coming years. It is forecast to reach $1.39 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.9%. The anticipated growth during this period can be attributed to factors such as an increasing preference for accessories and consumables, a rise in NICU admissions, growing demand for personalized medicine, an increase in premature births, and heightened research and development activities. Significant trends expected during the forecast period include automation in neonatal intensive care units (NICUs), the integration of artificial intelligence (AI), continuous technological advancement in neonatal care, innovations in surfactant therapy, and the adoption of advanced ventilator technologies.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20899&type=smp
What Are The Emerging Market Drivers Creating New Opportunities In The Neonatal Respiratory Distress Syndrome Treatment Industry?
The increasing occurrence of premature births is anticipated to drive the expansion of the neonatal respiratory distress syndrome treatment market in the future. Premature birth, also known as preterm birth, occurs when a baby arrives prior to 37 weeks of gestation, with infants born before 32 weeks encountering the highest health risks, given that a standard pregnancy typically spans around 40 weeks. The incidence of premature births is on the rise, attributed to various factors including advanced maternal age, pregnancies involving multiple fetuses, existing health issues, personal lifestyle decisions, the application of fertility interventions, infections, and environmental influences. Neonatal respiratory distress syndrome (NRDS) frequently affects premature babies because of their immature lungs and inadequate surfactant production. This treatment aids in enhancing lung functionality, stabilizing respiration, and lowering the likelihood of respiratory failure among premature infants. As an illustration, data from Tommy’s, a UK-based charity organization, indicated that in December 2022, the proportion of premature live births in England and Wales reached 7.9% in 2022, an increase from 7.5% in 2021. This represented the second consecutive year of an increase in premature births. In 2022, more than 53,000 babies were born prematurely. Consequently, the growing occurrence of premature births is propelling the neonatal respiratory distress syndrome treatment market.
What Are The Leading Segments Analyzed In The Neonatal Respiratory Distress Syndrome Treatment Market?
The neonatal respiratory distress syndrome treatmentmarket covered in this report is segmented –
1) By Therapy: Oxygen Therapy; Surfactant Therapy
2) By Route Of Administration: Parenteral; Inhalation; Other Routes Of Administration
3) By End User: Hospitals; Sub-Acute Facilities; Home Care; Retail Pharmacies
Subsegments:
1) By Oxygen Therapy: Conventional Oxygen Therapy; High-Flow Nasal Cannula (HFNC) Oxygen Therapy; Continuous Positive Airway Pressure (CPAP) Oxygen Therapy; Invasive Mechanical Ventilation With Oxygen Therapy
2) By Surfactant Therapy: Natural Surfactants; Synthetic Surfactants; Combined Surfactant Therapy (Natural + Synthetic); Prophylactic Surfactant Therapy; Rescue Surfactant Therapy
Which Market Trends Are Creating New Opportunities In The Neonatal Respiratory Distress Syndrome Treatment Industry?
Leading firms within the neonatal respiratory distress syndrome treatment market are focusing their efforts on creating sophisticated technologies, specifically nitric oxide generators, with the aim of improving oxygenation, reducing breathing complications, and providing non-invasive care for newborns experiencing hypoxic respiratory failure. This medical apparatus, a nitric oxide generator, produces and delivers nitric oxide gas, frequently employed to manage respiratory problems through enhanced oxygenation and the reduction of pulmonary hypertension, especially in infants and severely ill individuals. As an illustration, in June 2022, Beyond Air Inc., a medical device and biopharmaceutical company based in the US, secured FDA approval for its product, LungFit PH. This novel nitric oxide generator is specifically engineered to address hypoxic respiratory failure, including persistent pulmonary hypertension of the newborn (PPHN), in both term and near-term neonates. Leveraging Beyond Air’s proprietary Ionizer technology, the unit produces nitric oxide as needed from the surrounding air, ensuring an uninterrupted supply free from dose or flow limitations. It also employs a low-power compressor to ionize nitrogen and oxygen, thereby reducing the formation of nitrogen dioxide (NO2), which is subsequently removed safely by a smart filter.
Which Major Firms Are Strengthening Their Position In The Neonatal Respiratory Distress Syndrome Treatment Industry?
Major companies operating in the neonatal respiratory distress syndrome treatment market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Medtronic Plc, Medline Industries, Becton Dickinson, Stryker Corporation, GE Healthcare, Koninklijke Philips NV, ResMed Inc., Drägerwerk AG & Co. KGaA, Chiesi Farmaceutici, ICU Medical Inc., Fisher & Paykel Healthcare, Vyaire Medical, Laerdal Medical, Hamilton Medical, Inspiration Healthcare, Ventec Life Systems, Neotech Products, Aerogen Pharma Corp., Windtree Therapeutics Inc., Discovery Laboratories Inc., Lyomark Pharma GmbH
Download The Full Report For Exclusive Market Findings:
How Is Neonatal Respiratory Distress Syndrome Treatment Market Demand Varying Across Different Regions?
North America was the largest region in the neonatal respiratory distress syndrome treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal respiratory distress syndrome treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Neonatal Respiratory Distress Syndrome Treatment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=20899&type=smp
Browse Through More Reports Similar to the Global Neonatal Respiratory Distress Syndrome Treatment Market 2025, By The Business Research Company
Fetal And Neonatal Monitoring Devices Global Market Report 2025
Neonatal Infant Care Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/neonatal-infant-care-global-market-report
Pediatric And Neonatal Testing Kit Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
